Current featured projects
Treatments for juvenile idiopathic arthritis
SHTAC is assessing the clinical-effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for the treatment of juvenile idiopathic arthritis.
Tests for diagnosing pre-eclampsia in pregnancy
SHTAC is critically evaluating the clinical accuracy and cost-effectiveness of tests for diagnosing pre-eclampsia.
Second-eye cataract surgery research by SHTAC to be presented at the iHEA 11th World Congress, Milan 2015
SHTAC welcomes new Director, Professor Joanne Lord
NICE recommends omalizumab as treatment for severe chronic spontaneous urticaria
SHTAC's expertise in evidence synthesis has allowed us to develop training courses in systematic reviews and health economic evaluations.
SHTAC is involved in research addressing major policy questions on the use of drugs, devices, procedures, screening programmes, health promotion and public health and other interventions.